National Vision Holdings EBITDA Margin 2015-2023 | EYE
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for National Vision Holdings (EYE) over the last 10 years. The current EBITDA margin for National Vision Holdings as of December 31, 2023 is .
| National Vision Holdings EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2023-12-31 | $2.13B | $0.06B | 2.78% |
| 2023-09-30 | $2.09B | $0.07B | 3.16% |
| 2023-06-30 | $2.06B | $0.16B | 7.59% |
| 2023-03-31 | $2.04B | $0.17B | 8.14% |
| 2022-12-31 | $2.01B | $0.17B | 8.47% |
| 2022-09-30 | $2.02B | $0.19B | 9.23% |
| 2022-06-30 | $2.03B | $0.22B | 10.91% |
| 2022-03-31 | $2.07B | $0.26B | 12.45% |
| 2021-12-31 | $2.08B | $0.28B | 13.52% |
| 2021-09-30 | $2.10B | $0.33B | 15.59% |
| 2021-06-30 | $2.07B | $0.33B | 16.08% |
| 2021-03-31 | $1.78B | $0.24B | 13.23% |
| 2020-12-31 | $1.71B | $0.19B | 11.16% |
| 2020-09-30 | $1.62B | $0.14B | 8.60% |
| 2020-06-30 | $1.56B | $0.09B | 5.82% |
| 2020-03-31 | $1.73B | $0.15B | 8.71% |
| 2019-12-31 | $1.72B | $0.16B | 9.40% |
| 2019-09-30 | $1.68B | $0.13B | 7.81% |
| 2019-06-30 | $1.63B | $0.12B | 7.04% |
| 2019-03-31 | $1.59B | $0.12B | 7.23% |
| 2018-12-31 | $1.54B | $0.12B | 7.74% |
| 2018-09-30 | $1.50B | $0.13B | 8.92% |
| 2018-06-30 | $1.46B | $0.15B | 10.19% |
| 2018-03-31 | $1.41B | $0.14B | 9.55% |
| 2017-12-31 | $1.38B | $0.13B | 9.67% |
| 2017-06-30 | $1.01B | $0.10B | 9.71% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.388B | $2.126B |
| National Vision Holdings, Inc. is one of the leading and rapidly growing optical retailers in the U.S. It provides budget-friendly eye exams, eyeglasses and contact lenses to low-income consumers and aims at making eye care and eyewear reasonable for all Americans. The company operates through a diverse portfolio of retail stores across brands and consumer websites. The company uses third-party carriers to transport all products from the distribution centers to the destination. It operates through 2 reportable segments. Owned & host segment includes the company's owned brands, namely, America's Best and Eyeglass World along with its Vista Optical locations in Fred Meyer stores. National Vision also provides affordable eye care products and services to American military service members within the owned & host segment. Legacy segment comprises National Vision's old strategic collaboration with Walmart to run to Vision Centers in certain Walmart stores. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $185.474B | 24.35 |
| Stryker (SYK) | United States | $128.161B | 31.78 |
| Boston Scientific (BSX) | United States | $106.966B | 34.07 |
| Medtronic (MDT) | Ireland | $106.730B | 15.11 |
| EssilorLuxottica (ESLOY) | France | $99.574B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.648B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.127B | 29.82 |
| ResMed (RMD) | United States | $27.032B | 27.03 |
| Terumo (TRUMY) | Japan | $25.476B | 35.98 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.896B | 16.03 |
| Baxter (BAX) | United States | $20.785B | 15.16 |
| Koninklijke Philips (PHG) | Netherlands | $19.474B | 15.53 |
| Insulet (PODD) | United States | $11.711B | 61.49 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.741B | 0.00 |
| Demant (WILYY) | Denmark | $9.943B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.934B | 23.64 |
| BellRing Brands (BRBR) | United States | $7.285B | 39.17 |
| Lantheus Holdings (LNTH) | United States | $4.470B | 11.54 |
| Haemonetics (HAE) | United States | $4.379B | 22.40 |
| Perrigo (PRGO) | Ireland | $4.232B | 12.10 |
| GN Store Nord (GNNDY) | Denmark | $3.937B | 25.50 |
| Envista Holdings (NVST) | United States | $3.485B | 13.26 |
| Prestige Consumer Healthcare (PBH) | United States | $3.482B | 16.46 |
| QuidelOrtho (QDEL) | United States | $2.730B | 9.91 |
| Neogen (NEOG) | United States | $2.679B | 25.77 |
| Green Thumb Industries (GTBIF) | United States | $2.630B | 83.33 |
| ICU Medical (ICUI) | United States | $2.357B | 17.58 |
| TG Therapeutics (TGTX) | United States | $2.161B | 699.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.928B | 0.00 |
| Owens & Minor (OMI) | United States | $1.895B | 18.19 |
| Verano Holdings (VRNOF) | United States | $1.790B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.780B | 0.00 |
| InMode (INMD) | Israel | $1.458B | 7.55 |
| LeMaitre Vascular (LMAT) | United States | $1.437B | 47.43 |
| AdaptHealth (AHCO) | United States | $1.300B | 9.78 |
| Warby Parker (WRBY) | United States | $1.287B | 0.00 |
| AtriCure (ATRC) | United States | $1.115B | 0.00 |
| MacroGenics (MGNX) | United States | $0.982B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.899B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.779B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.712B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.693B | 14.98 |
| Evolus (EOLS) | United States | $0.666B | 0.00 |
| Quanterix (QTRX) | United States | $0.613B | 0.00 |
| Jin Medical (ZJYL) | China | $0.547B | 0.00 |
| Valneva SE (VALN) | France | $0.540B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.509B | 11.02 |
| PetIQ (PETQ) | United States | $0.487B | 18.17 |
| TerrAscend (TSNDF) | Canada | $0.478B | 0.00 |
| ZimVie (ZIMV) | United States | $0.430B | 26.35 |
| OraSure Technologies (OSUR) | United States | $0.421B | 6.96 |
| Biote (BTMD) | United States | $0.417B | 3.96 |
| Aurora Cannabis (ACB) | Canada | $0.393B | 0.00 |
| Surmodics (SRDX) | United States | $0.371B | 40.11 |
| Zynex (ZYXI) | United States | $0.361B | 41.59 |
| Viemed Healthcare (VMD) | United States | $0.314B | 31.11 |
| Cerus (CERS) | United States | $0.301B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.280B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.274B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.241B | 14.70 |
| Organigram Holdings (OGI) | Canada | $0.199B | 0.00 |
| Veru (VERU) | United States | $0.193B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.192B | 0.00 |
| Omeros (OMER) | United States | $0.176B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.163B | 0.00 |
| High Tide (HITI) | Canada | $0.160B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.159B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.134B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.130B | 65.20 |
| FitLife Brands (FTLF) | United States | $0.129B | 20.74 |
| InterCure (INCR) | Israel | $0.122B | 20.54 |
| Fonar (FONR) | United States | $0.102B | 8.80 |
| Cellectar Biosciences (CLRB) | United States | $0.099B | 0.00 |
| MariMed (MRMD) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.088B | 0.00 |
| Brainsway (BWAY) | Israel | $0.084B | 0.00 |
| Safety Shot (SHOT) | United States | $0.081B | 0.00 |
| Chimerix (CMRX) | United States | $0.081B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.060B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.059B | 3.86 |
| Apyx Medical (APYX) | United States | $0.052B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.045B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.039B | 15.04 |
| Bright Green (BGXX) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| Flora Growth (FLGC) | United States | $0.020B | 0.00 |
| Agape ATP (ATPC) | $0.020B | 0.00 | |
| FSD PHARMA (HUGE) | Canada | $0.018B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 72.54 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.001B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |